Ignite Creation Date:
2024-05-05 @ 9:36 PM
Last Modification Date:
2024-10-26 @ 10:07 AM
Study NCT ID:
NCT00926107
Status:
TERMINATED
Last Update Posted:
2011-11-10
First Post:
2009-06-22
Brief Title:
Study of the mTOR Inhibitor Temsirolimus CCI-779 to Treat Ovarian Cancer With CA125 Only Relapse
Sponsor:
Hellenic Cooperative Oncology Group
Organization:
Hellenic Cooperative Oncology Group
Organization Data
Organization:
Hellenic Cooperative Oncology Group
Class:
OTHER
Study ID:
HE 409
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hellenic Cooperative Oncology Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None